If an HIV-positive patient's viral load test results come back between 50 copies/mL and 200 copies/mL, consider retesting the same blood sample, Joseph Eron Jr., M.D., recommends. New study results suggest that the retest results may alter a clinicia...
High-dose, long-term omega-3 supplementation appears to yield improved triglycerides and C-reactive protein levels among HIV-positive people who have elevated triglycerides, but only after more than a year of use, a new study has found.
Virological Response Without Routine Viral Load Monitoring in Children: Results From the ARROW Trial
Reassuring virological outcomes without routine viral load monitoring shown in the ARROW trial but viral rebound greater than 5000 copies/mL should prompt switch to second-line, according to data presented 8th International Workshop on HIV Paediatric...
The Swiss HIV Cohort Study presented additional data at this year's International AIDS Conference showing that life expectancy has increased another 34 years for a person who is on HIV treatment and in care.
Starting ART in primary compared to chronic HIV infection had a significantly higher chance of getting a CD4:CD8 ratio >1.0 in a retrospective study in which individuals were their own controls.
An analysis from the START study reported that the CD4:CD8 ratio was a better predictor of risk compared to the CD4 count in people with strong immune function.
Paul Sax, M.D., provides a brief rundown of important prevention, treatment and complications research presented at the International AIDS Conference, and whatever else happened to catch his eye.
This Week in HIV Research: Taking Treatment 4 Days a Week Maintains Viral Suppression, and On-Demand PrEP Highly Effective
This week, a study finds that taking antiretroviral therapy from Monday to Thursday, while taking weekends off, maintained undetectable viral loads for the majority of study participants.
Researchers found that certain factors played an important role in reducing survival among HIV-positive people, including co-infection with hepatitis-causing viruses, excessive intake of alcohol, substance use and tobacco smoking.
Even with current HIV treatment, there are still barriers to care and complications. To help identify and address these obstacles, we asked some leading HIV experts and advocates what they think is the most overlooked issue in HIV care today.